GUJARAT THEMIS BIOSYN
Back to Balance Sheet
|
GUJARAT THEMIS BIOSYN Last 5 Year Contingent Liabilities History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Contingent Liabilities | ₹3.73 Cr | ₹4.03 Cr | ₹4.00 Cr | ₹3.88 Cr | ₹3.72 Cr |
What is the latest Contingent Liabilities ratio of GUJARAT THEMIS BIOSYN ?
Year | Contingent Liabilities |
---|---|
Mar2024 | ₹3.73 Cr |
Mar2023 | ₹4.03 Cr |
Mar2022 | ₹4.00 Cr |
Mar2021 | ₹3.88 Cr |
Mar2020 | ₹3.72 Cr |
How is Contingent Liabilities of GUJARAT THEMIS BIOSYN Trending?
Years | Contingent Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹3.73 Cr | -7.56 | |
Mar2023 | ₹4.03 Cr | 0.98 | |
Mar2022 | ₹4.00 Cr | 3.10 | |
Mar2021 | ₹3.88 Cr | 4.17 | |
Mar2020 | ₹3.72 Cr | - |
Compare Contingent Liabilities of peers of GUJARAT THEMIS BIOSYN
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
GUJARAT THEMIS BIOSYN | ₹2,933.7 Cr | -1.4% | 2.8% | -6.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹418,648.0 Cr | -4.9% | 2.1% | 15.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹159,310.0 Cr | -2.2% | 9.3% | 50.5% | Stock Analytics | |
CIPLA | ₹119,410.0 Cr | -4.2% | 4.5% | 4.5% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹106,189.0 Cr | -4.4% | -4.5% | 17.2% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹96,496.4 Cr | -1.4% | 4.2% | -8.8% | Stock Analytics |
GUJARAT THEMIS BIOSYN Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
GUJARAT THEMIS BIOSYN | -1.4% |
2.8% |
-6.3% |
SENSEX | -1.3% |
4.1% |
7.6% |
You may also like the below Video Courses